Cargando…
Crystal Structure of CYP3A4 Complexed with Fluorol Identifies the Substrate Access Channel as a High-Affinity Ligand Binding Site
Cytochrome P450 3A4 (CYP3A4) is a major human drug-metabolizing enzyme, notoriously known for its extreme substrate promiscuity, allosteric behavior, and implications in drug–drug interactions. Despite extensive investigations, the mechanism of ligand binding to CYP3A4 is not fully understood. We de...
Autor principal: | Sevrioukova, Irina F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604483/ https://www.ncbi.nlm.nih.gov/pubmed/36293445 http://dx.doi.org/10.3390/ijms232012591 |
Ejemplares similares
-
Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding
por: Sevrioukova, Irina F.
Publicado: (2023) -
Structural Basis for the Diminished Ligand Binding and Catalytic Ability of Human Fetal-Specific CYP3A7
por: Sevrioukova, Irina F.
Publicado: (2021) -
Rational Design of CYP3A4 Inhibitors: A One-Atom Linker Elongation in Ritonavir-Like Compounds Leads to a Marked Improvement in the Binding Strength
por: Samuels, Eric R., et al.
Publicado: (2021) -
Enhancement of crystallization with nucleotide ligands identified by dye-ligand affinity chromatography
por: Kim, Heungbok, et al.
Publicado: (2012) -
New ligand-binding sites identified in the crystal structures of β-lactoglobulin complexes with desipramine
por: Loch, Joanna I., et al.
Publicado: (2022)